4.7 Editorial Material

Epigenetic Events in Gastrointestinal Cancer

Journal

AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 104, Issue 8, Pages 1910-1912

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ajg.2008.145

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA095323, U01 CA085069-06, U24 CA115091, U24 CA115091-01, 3 R01 CA95323-11A2, U01 CA085069, R01 CA095323-11, 2 R01 CA85069-06] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK087454, T32 DK067872] Funding Source: Medline

Ask authors/readers for more resources

Epigenetics refers to heritable changes in gene expression that are, unlike mutations, not attributable to alterations in DNA sequence. Two predominant epigenetic mechanisms are DNA methylation and histone modification. Epigenetic regulation of gene expression has emerged as a fundamental pathway in the pathogenesis of numerous malignancies, including cancers of the digestive system-in fact, many exciting discoveries in epigenetics have come out of the study of cancers of the gastrointestinal tract and hepatobiliary tree. Epigenetic modifications of DNA in cancer and precancerous lesions offer the promise of novel biomarkers for early cancer detection, prediction, prognosis, and response to treatment. Furthermore, reversal of epigenetic changes represents a potential target of novel therapeutic strategies and medication design. In the future, innovative diagnostic tests and treatment regimens will likely be based on epigenetic mechanisms and be incorporated into the gastroenterologist's practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available